Cover Image
Market Research Report

Private Equity and Venture Capital Investment in the Global Pharmaceutical and Biotechnology Industry

Published by Frost & Sullivan Product code 296265
Published Content info 58 Pages
Delivery time: 1-2 business days
Price
Back to Top
Private Equity and Venture Capital Investment in the Global Pharmaceutical and Biotechnology Industry
Published: February 12, 2014 Content info: 58 Pages
Description

Vigilance and Equanimity are the Needs of the Hour

This study for the private equity and venture capital trends in the global pharmaceutical and biotechnology industry analyzes the various deals in the industry. The deals are analyzed based on number and average value. The trends are also observed based on the geographic region and buyer types. The study delves into the nature of cross border deals and also keeps into account various deal multiples such as deal value and investment rounds. The distribution of deals across key therapeutic areas has been dealt to understand the focus of investors and to highlight the key therapeutic areas in the near future. The analysis also includes geography-wise interest of buyers in regions across other geographies in terms both deal value and volume.

Table of Contents
Product Code: ND74-01-00-00-00

Table of Contents

  • 1. Key Terms Used in the Study
  • 2. Introduction
  • 3. Key Trends in the Pharma and Biotech Industry
  • 4. Key PEVC Statistics
  • 5. VC Deals-Key Metrics
  • 6. Deal Value Range Analysis
  • 7. Geographic Analysis
  • 8. Analysis of the Exit Market
  • 9. Analysis of Deals Based on Key Therapeutic Areas
  • 10. Conclusion
  • 11. The Frost & Sullivan Story
Back to Top